Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study

Enrolling by invitation

Conditions studied: Ischemic Stroke

In brief

The purpose of this long-term safety study is to follow up subjects treated with CTX0E03 DP to monitor for delayed oncological, neurological, and CTX0E03 DP-related adverse events and to monitor survival

Key facts

Study ID

NCT05598775

Run by

ReNeuron Limited

People needed

9

Starts

2022-11-01

Expected to finish

2026-12-31

Last updated by the study team

2023-03-31

Who can join

Age: 35 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have received CTX0E03 DP as part of the active arm in the PISCES III study Have provided appropriate written informed consent

You may not qualify if…

• None

Where it is running

• Amy Miller, RPh, PharmD — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.